An Ethical Analysis of Pharmacy Benefit Manager (PBM) Practices.

ABSTRACT: The high costs associated with pharmaceuticals and the accompanying stakeholders are being closely evaluated in the search for solutions. As a major stakeholder in the U.S. pharmaceutical market, the practices of pharmacy benefit manager (PBM) organizations have been under increased scrutiny. Examples of controversial practices have included incentives driving formulary status and prohibiting pharmacists from disclosing information on lower-cost prescription alternatives. Ethical investigations have been largely omitted within the debate on the responsibilities of these organizations in the health care system. Ethical analysis of organizational practices is justified based on the potential impact during health care delivery. The objective of this study was to analyze several specific PBM p

SUBMITTER: Drettwan JJ 

PROVIDER: S-EPMC6631892 | biostudies-literature | 2019 Jun

REPOSITORIES: biostudies-literature